Covid vaccine side effects: Three symptoms following the jab you must not ignore
On 8 December 2020, the UK became the first country to roll out a COVID-19 vaccination programme. Vaccine effectiveness is estimated by comparing rates of disease in vaccinated individuals to rates in unvaccinated individuals.
Public Health England (PHE) and other government and academic partners monitor the impact of the of the vaccination programme on levels of COVID-19 antibodies.
It was reported that most adults under the age of 40 will be given an alternative to the Oxford-AstraZeneca vaccine due to its link with rare blood clots.
The chances of a younger person becoming seriously ill with COVID-19 get smaller as infection rates increasingly come under control in the UK.
Most clots were after the first dose and people who have already had one dose of Oxford-AstraZeneca are advised to still have the second.
However, some under 40s will still be offered the Oxford-AstraZeneca vaccine as it is easier to both transport and store, making it more practical than the alternatives.
READ MORE: Arthritis symptoms: Four ‘weird and unusual’ signs of arthritis pain you might be missing
